Coelho Rogerio Vivaldi - Jan 3, 2022 Form 3 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Director
Signature
/s/Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
3
Date filed
1/10/2022, 03:29 PM
Previous filing
Nov 5, 2021
Next filing
Feb 22, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power-of-Attorney